Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Expert Rev Clin Immunol. 2007 Nov;3(6):913-23. doi: 10.1586/1744666X.3.6.913.

Defining a new molecular basis of systemic lupus erythematosus through transcriptional profiling.

Author information

  • 1Oklahoma Medical Research Foundation, Arthritis and Immunology Program, 825 N.E. 13th Street, Oklahoma City, OK 73104, USA. gaffneyp@lupus.omrf.org

Abstract

Data generated using high-throughput DNA microarrays are changing the way we think about systemic lupus erythematosus (SLE). The identification of an interferon gene-expression signature in the majority of patients with SLE, especially those with severe SLE, has stimulated substantial interest in targeting the interferon pathway for the treatment SLE and has catalyzed new inquiries into the utility of interferon signaling as a diagnostic and prognostic biomarker for SLE. As these genomic datasets enlarge and mature, new signatures are being identified that implicate other pathways dysregulated in SLE, including oxidative phosphorylation, immunoglobulin production and granulocyte maturation. Highly anticipated longitudinal studies will be important in defining how this information will ultimately change the way SLE is managed in the clinical setting.

PMID:
20477140
[PubMed]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk